Drugmakers, insurers, hospitals, pharmacies, medical devices, clinical updates, and healthcare business leaders.
A Yahoo Finance report says Pfizer’s second-quarter update included higher full-year revenue guidance and steady non-COVID product performance, even as it reported a net loss and sizable non-cash impairments. The article frames the move as a potential valuation catch-up for the company’s earnings expectations.
THE APEX TIMES
THE APEX TIMES
Eli Lilly reported a sharp rebound in sales for the quarter, sending its stock higher, as momentum in GLP-1 medicines appeared to widen its competitive gap with Novo Nordisk.
THE APEX TIMES
A new market note argues the healthcare sector has been overlooked this year and flags a basket of stocks, including Eli Lilly (LLY) and McKesson, as potential beneficiaries if investors broaden beyond the year’s biggest winners.
THE APEX TIMES
Eli Lilly opened Wednesday’s session on a sharply higher note after reporting a blowout quarter, reinforcing investor focus on the durability of demand for its weight-loss pipeline and manufacturing ramp.
THE APEX TIMES
In an earnings call recap shared by Yahoo Finance, CVS Health said adjusted earnings surged and the company increased its full-year guidance, while pointing to strategic initiatives meant to offset challenges expected in 2027.
THE APEX TIMES
Texas MedClinic, a San Antonio-founded urgent care chain that grew to 40 locations across the Alamo City, Austin and Houston metro areas, is transitioning its clinics following HCA Healthcare’s acquisition, according to a report published this week.
THE APEX TIMES
A new collaboration between CVS Health and Eli Lilly is aimed at improving patient access to GLP-1 medicines, according to a report cited by Yahoo Finance, in a week when investors also scanned major healthcare names for second-quarter outlines.
THE APEX TIMES
A Yahoo Finance recap summarizes CVS Health’s Q2 2026 earnings call, but provides limited detail on specific operating metrics in the information reviewed for this report.
THE APEX TIMES
CVS Health reported second-quarter net income of $2.9 billion, nearly tripling from the year-ago period, citing improvements in how it is managing costs tied to its Aetna health plan.
